Navigation Links
Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies

muscle mass and strength is expected to produce a major clinical benefit across this broad range of serious medical conditions in which there are currently no safe and effective therapies that selectively increase skeletal muscle mass and strength.

About Acceleron Pharma
Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of bone, muscle, fat and the vasculature to treat musculoskeletal, metabolic and cancer-related diseases. Acceleron¹s scientific approach takes advantage of its unique insight on the regenerative powers of two protein families: the Growth and Differentiation Factor (GDF) and Bone Morphogenetic Protein (BMP) families. The company¹s lead program is an anabolic bone agent being developed to reverse bone loss in diseases such as osteoporosis and cancer. Additionally, the company is advancing several preclinical programs that increase muscle mass, control angiogenesis and inhibit fat accumulation. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company¹s internal GMP manufacturing capability to rapidly and efficiently advance its therapeutic programs. The investors in Acceleron are Advanced Technology Ventures, Flagship Ventures, OrbiMed Advisors, Polaris Ventures, Sutter Hill Ventures and Venrock.

Contact: Steven Ertel, Vice President, Business Development, Acceleron Pharma, tel: 617-520-1334 and Paul Kidwell (Media) Suda Communications, tel: 617-296-3854 Paul Kidwell 617.296.3854: Office 617.680.1088: Mobile


'"/>




Page: 1 2 3

Related medicine technology :

1. Acceleron Pharmas ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
2. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
3. Rapid HIV Testing Increases Possibility of Treatment
4. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
5. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
6. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
7. Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
8. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
9. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
10. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
11. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Post Your Comments:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: ... development and commercialization of products for central nervous ... two posters at the Society for Research on ... The first poster entitled Pleiomorphic ... provides insight into the challenges faced by ...
(Date:5/22/2012)... -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it ... and Drug Administration for its abbreviated new drug ... the generic equivalent of Gynazole·1®. Perrigo was the first ... a paragraph IV certification and is entitled to ... KV Pharmaceutical Company on a collaboration to launch ...
(Date:5/22/2012)... AUSTIN, Texas, May 22, 2012  Prodigy Generics, ... has launched injectable irinotecan. Irinotecan is the generic ... Prodigy partnered with eVenus Pharmaceutical Laboratories ... is the first of several ANDAs being developed ... and exceptional value to the U.S. injectable market, ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3Infant Organ Donors Could Help Meet Transplant Needs 3A Study 78200 1Infant Organ Donors Could Help Meet Transplant Needs 3A Study 78200 2Scripps Research chemist devises new method to quantify protein changes 17165 1Scripps Research chemist devises new method to quantify protein changes 17165 2Scripps Research chemist devises new method to quantify protein changes 17165 3Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC 1002 13706 1Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC 1002 13706 2
(Date:5/23/2012)... research suggests that young asthma patients who use drugs ... -- could be more likely than others to suffer ... increased risk was not seen for some types of ... the recent interest in use of anticholinergics in asthma," ... at Chicago, said in a news release from the ...
(Date:5/23/2012)... treatment with inhaled corticosteroids in patients with respiratory ... associated with a lower incidence and severity of ... researchers in Spain. , A parapneumonic effusion is ... accumulates between the two pleural layers, the fluid-filled ... a result of a pneumonia, lung abscess, or ...
(Date:5/22/2012)... Ill. Magnetic resonance imaging (MRI) provides an ... chemotherapy significantly earlier than possible through clinical examination, ... the journal Radiology . , Women ... surgery. Research has shown that women who receive ... likely to achieve breast conservation than those receiving ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) -- ... common cause of snoring and daytime sleepiness, might also ... the condition -- the risk of developing high blood ... new cases of high blood pressure in two groups ... therapy, or CPAP, for either about four or 11 ...
(Date:5/22/2012)... 22, 2012) -- Researchers at Barrow Neurological Institute ... unveiled how and why the public perceives some ... real-world implications in military tactics, marketing and sports. ... Visual Neuroscience, and Stephen Macknik, PhD, of Barrow,s ... their research into magic and illusions. Their most ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... planning to recruit 50,000 people as a part of a large ... relationship // between lifestyle and genetics as regards the health of ... two decades and is one of the largest healthcare projects in ... large pool of information so that it would be easy to ...
... Life of Life Healing Spa is increasingly getting more customers ... the very first session. // Owner Karen Chu claims that ... degree of success since the spa first began offering the ... given here has not yet resulted in any injuries. Most ...
... after eating a single sweet as she suffered from nut ... cream cake but had // failed to identify the chocolate-covered ... and lost consciousness in an hour’s time. She was immediately ... causing irreversible brain damage. , ,Five days later, ...
... and cancer drugs which it hopes will increase its sales ... starting // to market two of its new diabetes drug ... treating type 2 diabetes. ,The drug Avandaryl is ... the drug Avandamet is produced by the combination of Avandina ...
... countrymen safe drinking water within a matter of four ... // to make this possible. Most people living in ... water. ,Inaugurating a conference of ministers ... sanitation in states and union territories, the prime minister ...
... per a study in Tanzania by Duke University Medical Centre, it ... cost effective than charging a small fee for them. // ... free test rather than a charged test. ,The statistics ... a two-week pilot program in 2003. ,The numbers which ...
Other Medicine News:Health News:Safe Drinking Water To Be Made Available 2Health News:Free HIV Tests far more cost effective than small fee 2
... CryoCath has developed a minimally ... reentrant tachycardia. It delivers a very ... site confirmation, pinpoint site precision, minimal ... thrombus and stenosis., ,Freezor Xtra allows ...
... CryoCath has developed a minimally invasive ... tachycardia. It delivers a very high ... confirmation, pinpoint site precision, minimal tissue ... and stenosis., ,Freezor is a flexible, ...
The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
Ten-Ten duodecapolar diagnostic mapping catheters are available in four curve sizes....
Medicine Products: